tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders StocksMarket MoversTipRanks 50 IndexAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Trending StocksCompare StocksCompare ETFsTrump Dashboard
New
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksFDA CalendarMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Trending News
More News >
Education
Personal FinanceHow To Use TipRanksTipRanks LabsGlossaryFAQs
About Us
About TipRanksContact UsReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News Wire
Follow Us
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Trump Dashboard
New
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
FDA Calendar
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Private Companies
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Taysha Gene Therapies (TSHA)
NASDAQ:TSHA
US Market
TSHA
Taysha Gene Therapies
RESEARCH TOOLSreports

Taysha Gene Therapies (TSHA) Stock News & Sentiment

Compare
1,243 Followers
Aehr, Fastenal, Regions, Abeona, Taysha: Insider Firestorm
Premium
Weekend Updates
Aehr, Fastenal, Regions, Abeona, Taysha: Insider Firestorm
4d ago
RF
ABEO
Regulatory Clarity and Broad Rett Syndrome Opportunity Drive Taysha Gene Therapies Buy Rating and $10 Target
Premium
Ratings
Regulatory Clarity and Broad Rett Syndrome Opportunity Drive Taysha Gene Therapies Buy Rating and $10 Target
29d ago
TSHA
Taysha Gene Therapies Advances TSHA-102 Program
Premium
Company Announcements
Taysha Gene Therapies Advances TSHA-102 Program
3M ago
TSHA
Taysha Gene Therapies’ Earnings Call Highlights Progress and Challenges
Premium
Company Announcements
Taysha Gene Therapies’ Earnings Call Highlights Progress and Challenges
3M ago
TSHA
Taysha Gene Therapies: Advancing REVEAL Study and Mitigating Regulatory Risks Earns Buy Rating
Premium
Ratings
Taysha Gene Therapies: Advancing REVEAL Study and Mitigating Regulatory Risks Earns Buy Rating
3M ago
TSHA
Taysha Gene Therapies Amends Sales Agreement, Expands Offering
Premium
Company Announcements
Taysha Gene Therapies Amends Sales Agreement, Expands Offering
3M ago
8K
TSHA
Is TSHA a Buy, Before Earnings?
Premium
Pre-Earnings
Is TSHA a Buy, Before Earnings?
3M ago
TSHA
More TSHA News >

TSHA News on the Web

Aehr, Fastenal, Regions, Abeona, Taysha: Insider Firestorm
TipRanks News
Bearish
Top Taysha Gene Therapies Insiders Make Major Moves With Their Own Shares
TipRanks News
Neutral
Regulatory Clarity and Broad Rett Syndrome Opportunity Drive Taysha Gene Therapies Buy Rating and $10 Target
TipRanks News
Bullish
Taysha Gene Therapies announces progress across TSHA-102
TipRanks News
Bullish
Why Taysha Gene Therapies, Inc.’s (TSHA) Stock Is Down 5.05%
AAII
Neutral
Why Taysha Gene Therapies, Inc.’s (TSHA) Stock Is Up 5.19%
AAII
Neutral
Why Taysha Gene Therapies, Inc.’s (TSHA) Stock Is Up 6.73%
AAII
Neutral
Why Taysha Gene Therapies, Inc.’s (TSHA) Stock Is Up 5.56%
AAII
Neutral

News Score - Last 7 Days

Negative
TSHA
Sector Average
Media Buzz
This Week1 articles
Weekly Average1 articles
News Sentiment
This Week0%
Sector Average72%
See how Bullish or Bearish a stock is based on its recent media coverage.

This score is generated using a formula that combines Media Buzz and News Sentiment.

Media Coverage Analysis

The historical news coverage of this asset in the last three months.

FAQ

What is TSHA’s Media Buzz Sentiment?
1 articles about TSHA were published this week. In an average week, 1 articles are published.
    What is TSHA’s weekly average amount of articles?
    In an average week, 1 articles about TSHA are published.
      What is TSHA’s News Sentiment?
      Currently, no data Available
      Healthcare Stocks that are Trending in the News
      QNCXQuince Therapeutics
      DVADaVita
      PLXProtalix
      RMDResmed
      UNCYUnicycive Therapeutics
      Showing the stocks with the most bullish news sentiment over the past week